Abstract
Introduction: Epstein-Barr virus (EBV) is associated with Post Transplant Lymphoproliferative Disease (PTLD). To investigate if patients at risk for PTLD can be identified early we measured the EBV viral load during the first 8 months after lung transplantation (Ltx). In addition we studied immunosuppression as a risk factor for PTLD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.